PAPER
Functionalisation of 2-(1-Naphthyl)-5-phenyl-1,3,4-oxadiazole with Alkoxysilanes
895
mmol) in anhyd DMF (30 mL) was placed in an autoclave, purged
with N2, and stirred under ethene (30 bar) for 40 h at 100 °C. The
cooled mixture was diluted with H2O (100 mL), extracted with
CHCl3 (3 × 50 mL), and the combined organic solutions were
washed with H2O (3 × 100 mL), and dried (MgSO4). The solvent
was evaporated and the residue was purified by chromatography on
silica gel (petroleum ether−EtOAc, 5:1). Yield: 0.58 g (69%),
slightly yellowish crystals, mp 134 °C.
with an efficient reflux condenser and bubble counter, and a gentle
flow of dry and O2-free N2 was bubbled through the solution to re-
move ethene (16 h, ambient temperature). The solvent was stripped
off and the residue purified by chromatography. Yield: 55 mg
(12%) of 8 and 250 mg (83%) of 11.
IR (neat): ν = 3040, 2960, 2915, 1595, 1567, 1520, 1483, 1450,
1380, 1290, 1195, 1161, 1097, 1070, 958, 802, 772, 750 cm−1.
1H NMR (CDCl3): δ = 1.30 (t, 9H, J = 7.0 Hz, CH3), 3.90 (q, 6H,
J = 7.0 Hz, OCH2), 6.35 (d, 1H, J = 19.6 Hz, vin), 7.24 (d, 1H,
J = 19.6 Hz, vin), 7.53–7.73 (m, 5H, ph, naph), 7.95 (d, 1H, J = 8.0
Hz, naph), 8.04 (d, 1H, J = 8.0 Hz, naph), 8.16 (d, 2H, J = 8.0 Hz, 2-
H, 6-H, ph), 8.26 (dd, 1H, J = 8.0, 1.0 Hz, naph), 9.29 (d, 1H, J = 8.4
Hz, naph).
13C NMR (CDCl3): δ = 18.3 (CH3), 58.7 (OCH2), 120.5, 123.7,
130.1, 133.9, 140.8 (Cq), 121.1, 124.9, 126.3, 126.8, 127.3 (2C),
127.4 (2C), 128.2, 128.4, 128.7, 132.7, 147.6 (CH), 164.0, 164.6
(C-2, C-5, oxadiazole).
IR (KBr): ν = 3070, 3040, 2990, 2910, 1615, 1600, 1565, 1520,
1485, 1400, 1242, 1090, 1070, 1008, 980, 925, 900, 842, 820, 770,
715, 696, 655 cm−1.
1H NMR (CDCl3): δ = 5.39 (d, 1H, J = 10.7 Hz, vin), 5.87 (d, 1H,
J = 17.5 Hz, vin), 6.77 (dd, 1H, J = 17.5, 10.7 Hz, vin), 7.59 (m, 3H,
ph, naph), 7.71 (2 × t, 2 × 1H, J = 8.5 Hz, naph), 8.15 (d, 2H, J = 8.0
Hz, ph), 7.93, 8.05, 8.26, 9.28 (4 d, 4 × 4 × 1H J = 8.4 Hz, 2-H, 4-H,
5-H, 8-H, naph).
13C NMR (CDCl3): δ = 116.4, 124.9, 126.3, 126.8, 126.9 (2C),
127.9 (2C), 128.2, 128.4, 128.7, 132.6, 135.9 (CH), 120.5, 123.0,
130.1, 133.9, 140.9 (Cq), 167.5, (oxd) (1 signal of the heterocycle is
missing).
MS (FD): m/z = 922 (1) [M2 ], 461 (100) [M+], 230.7 (1) [M2+].
+
2-(1-Naphthyl)-5-{4-[(1E)-3-(triethoxysilyl)-1-
propenyl]phenyl}-1,3,4-oxadiazole (9)
MS (EI): m/z = 298 (46) [M+], 241 (77), 215 (100).
Pd(OAc)2 (20 mg, 0.09 mmol), tris-o-tolylphosphine (55 mg,
0.18 mmol), and Et3N (0.43 g, 4.2 mmol) were added to a solution
of 3 (0.3 g, 0.85 mmol) and 6 (0.17 g, 0.85 mmol) in anhyd DMF
(30 mL) and stirred under N2 for 3 h at 115 °C. Extraction with tol-
uene-cyclohexane (1:1, 3 × 20 mL), washing with iced water, and
drying (MgSO4) was followed by chromatography on silica gel (tol-
uene−EtOAc, 5:1) to yield 270 mg (68%) of a slightly yellow solid,
mp 82 °C.
2-{4-[Diethoxy(methyl)silyl]ethenylphenyl}-5-(1-naphthyl)-
1,3,4-oxadiazole (7)
Prepared from 3 and 4 according to the procedure (a) described for
8. The reaction time was 2 h. The crude product was purified by col-
umn chromatography (silica gel, CHCl3−petroleum ether, 3:1).
Yield: 250 mg (42%) as a slowly crystallising yellowish oil, mp
98 °C.
The cross metathesis of 11 and 4, according to procedure (b) de-
scribed for 8, yielded <3% of 7.
IR (neat): ν = 3040, 2960, 2910, 2870, 1630, 1600, 1550, 1519,
1480, 1380, 1242, 1160, 1060, 955, 860, 802, 770, 740 cm−1.
IR (neat): ν = 3040, 2960, 2915, 1600, 1565, 1535, 1520, 1500,
1480, 1430, 1405, 1380, 1320, 1290, 1250, 1210, 1195, 1160, 1097,
1070, 1005, 802, 760, 735 cm−1.
1H NMR (CDCl3): δ = 0.30 (s, 3H, Si-CH3), 1.26 (t, 6H, J = 7.0 Hz,
CH3), 3.85 (q, 4H, J = 7.0 Hz, OCH2), 6.45 (d, 1H, J = 19.6 Hz, vin),
7.15 (d, 1H, J = 19.6 Hz, vin), 7.52–7.78 (m, 5H, ph, naph), 7.93 (d,
1H, J = 8.0 Hz, naph), 8.05 (d, 1H, J = 8.0 Hz, naph), 8.16 (d, 2H,
J = 8.0 Hz, 2-H, 6-H, ph), 8.26 (dd, 1H, J = 8.0, 1 Hz, naph), 9.27 (d,
1H, J = 8.8 Hz, naph).
13C NMR (CDCl3): δ = −4.2 (Si-CH3), 18.4 (CH3), 58.5 (OCH2),
120.5, 123.6, 130.2, 133.9, 141.0 (Cq), 124.9, 125.8, 126.3, 126.8,
127.3 (2C), 128.2, 128.4, 128.7, 132.6, 146.0 (CH), 164.0, 164.6
(C-2, C-5, oxadiazole).
1H NMR (CDCl3): δ = 1.28 (t, 9H, J = 7.0 Hz, CH3), 1.87 (dd, 2H,
J = 8.0, 1.0 Hz, Si-CH2), 3.86 (q, 6H, J = 7.0 Hz, OCH2), 6.42 (m,
2H, vin), 7.48 (d, 2H, J = 8.0 Hz, ph), 7.53–7.72 (m, 3H, naph), 7.94
(d, 1H, J = 8.0 Hz, naph), 8.04 (d, 1H, J = 8.0 Hz, naph), 8.11 (d, 2H,
J = 8.0 Hz, 2-H, 6-H, ph), 8.27 (dd, 1H, J = 8.0, 1.0 Hz, naph), 9.28
(d, 1H, J = 8.4 Hz, naph).
13C NMR (CDCl3): δ = 7.7 (Si-CH2), 18.2 (CH3), 22.7 (CH2), 40.5
(N-CH2), 58.4 (OCH2), 112.1 (2C), 115.0, 120.8, 126.2, 126.6,
127.9, 128.0, 128.3, 128.6, 130.0 (2C), 132.1, 133.8 (CH, Cq, 1 sig-
nal superimposed), 151.4 (C-N), 161.5, 164.9 (oxadiazole).
MS (FD): m/z = 475 (100) [M+].
2-(1-Naphthyl)-5{[4′-5(1-naphthyl)-1,3,4-oxadiazol-2-yl][1,1′-
biphenyl]-4-yl}-1,3,4-oxadiazole (10)
Procedure (a)
MS (FD): m/z = 431 (100) [M+], 215.7 (5) [M2+].
2-(1-Naphthyl)-5-{4-[(E)-2-(triethoxysilyl)ethenyl]phenyl}-
1,3,4-oxadiazole (8)
Procedure (a)
Synthesised according to the procedure described for 8 without add-
ing silane. After stirring for 5 h at 130–135 °C, the cooled mixture
was diluted with MeOH (60 mL) and the product was isolated by fil-
tration and washed with MeOH, CH2Cl2, and MeOH and dried.
Light orange plates with very poor solubility, yield: 153 mg, (6%);
mp 317 °C (Lit:21 mp 319–324 °C).
Pd(OAc)2 (20 mg, 0.089 mmol) and tris-o-tolylphosphine (50 mg,
0.180 mmol) were added to a solution of 3 (0.30 g, 0.89 mmol),
Et3N (0.45 g, 4.45 mmol) and silane 5 (0.17 g, 0.89 mmol) in anhyd
DMF (30 mL). The mixture was purged with N2 and stirred at
120 °C for 5 h. The cooled reaction mixture was stirred with a mix-
ture of cyclohexane and toluene (2:1, 4 × 40 mL) for 1 h, and the
combined hydrocarbon solutions were washed with iced water (3 ×
50 mL), and dried (MgSO4). Compound 8 was purified by chroma-
tography on silica gel (toluene−EtOAc, 5:1). Yield: 0.22 g (54%) as
a slowly crystallising yellowish oil, mp 118 °C.
Procedure (b)
A solution of α-naphthoylchloride (200 mg, 1.1 mmol) and 4,4′-
bis(5-tetrazolyl)biphenyl (145 mg, 0.5 mmol) in pyridine (3 mL)
was heated to 135 °C for 2 h. The hot mixture was poured into
MeOH (10 mL) and diluted with H2O (10 mL). The greenish solid,
isolated by filtration, was recrystallised from toluene. Yield: 155
1
mg (57%), orange powder. The spectra (IR, H NMR and MS) of
Procedure (b)
the compounds from both sources were identical.
Grubbs catalyst [Ru(PCy3)2(H5C6CH)]Cl2 (12, 2 mg) was added to
a solution of 5 (180 mg, 1 mmol) and 11 (300 mg, 1 mmol) in anhyd
benzene (8 mL) placed in a 2-necked round bottom flask equipped
IR (KBr): ν = 1570, 1503, 1470, 1398, 1245, 1185, 1125, 1090,
1070, 1025, 980, 960, 828, 797, 762, 735 cm−1.
Synthesis 2001, No. 6, 893–896 ISSN 0039-7881 © Thieme Stuttgart · New York